Product Overview
Dragon Pharma EQ 200 / Test E 200 is one 10 ml multi-dose vial holding two separate long esters: 200 mg of boldenone undecylenate and 200 mg of testosterone enanthate in every millilitre. That is 400 mg per mL on the label and 4000 mg per bottle, split evenly at a 1:1 ratio, in an MCT oil carrier, and the fixed ratio is the design: one draw carries both, so there is no vials-of-different-concentration arithmetic. Neither ester is 17-alpha-alkylated, so the first-pass liver load of oral products does not apply.
The vial runs on one stretched clock. Testosterone enanthate clears in 4.5 to 5 days intramuscularly and boldenone undecylenate in about 14, so the blend has no single half-life and its release curve spans roughly 4.5 to 14 days. That shape is the reason the two sit in one ampoule: androgen support arrives at once while the slower, leaner fraction is still accumulating, and the level then stays covered between shots. The estrogenic load sits lower than the 400 mg label implies, because boldenone aromatizes at a fraction of the testosterone rate without being dry, and erythrocytosis grows with dose and duration, so a decision about Arimidex is a question for blood work rather than for the calendar.
This suits lean mass and recomposition rather than a wet bulk, and it brings its own testosterone base, so no testosterone vial is needed on top. EQ 300 is the same boldenone ester alone for anyone who wants to set the testosterone dose separately, while Deca 200 / Test E 200 applies the one-vial idea to a 19-nor instead of boldenone. The practical objection is the tail: boldenone stays traceable for up to five months, so a tested athlete cannot use it safely.
Dosage Protocol
There is no approved dose for this exact mixture. The rows below apply the vendor's volume arithmetic for a 400 mg/mL vial, where 0.5 mL carries 100 mg of each arm, to the ranges in the fact base. Arithmetic of the bottle, not an instruction.
| Beginner | 0.5 mL twice a week, which is 200 mg boldenone plus 200 mg testosterone enanthate weekly - 12 to 14 weeks |
| Intermediate | 1 mL twice a week, so 400 mg of each arm weekly - 12 to 16 weeks; the vendor calls this the most referenced dose, and a 10 mL vial lasts five weeks at this volume |
| Advanced | 1.5 mL twice a week, so 600 mg of each arm weekly - 14 to 16 weeks; the top of the community range, where hematocrit monitoring matters, with one vial lasting about three weeks |
| Female | No documented protocol in the sources consulted; both arms carry virilization risk and no source describes a safe female schedule |
| Administration | Deep intramuscular injection every 3 to 4 days, that is twice weekly; the frequency holds the enanthate arm steady and suits the undecylenate arm; rotate sites |
Two vendor cross-checks fall inside the table: 400 to 800 mg weekly at the top level, and 400 to 600 mg weekly split into two injections.
Suggested Protocols
The blend is normally the base of a cycle and the rest of the stack is built around its stretch. Capsule links open Dragon Pharma pages.
Support follows the level rather than the calendar. An aromatase inhibitor such as Aromasin is dosed from estradiol results, HCG 5000 IU is referenced for the closing weeks of a long run, and recovery uses Nolvadex or Clomid. Weekly volume above 600 mg per arm belongs to users already tracking a full blood count.
What to Expect
- Weeks 1 to 2. The fast end of the curve is doing the work: the shorter ester is already releasing while the slower one is still building, so libido, mood and training drive change in this window.
- Weeks 2 to 4. The two rates overlap, so the level holds steady under twice-weekly shots while the slow fraction keeps accumulating.
- Weeks 4 to 6. Vendor and review material place the boldenone onset here: vascularity, a marked appetite increase and lean tissue accumulation begin to show.
- Weeks 10 to 16. Full expression of a long-ester run. Weight climbs more slowly and looks drier than a testosterone-only cycle of the same total milligrams, since testosterone is only half of the label.
- Blood work. Red cell mass and hematocrit can climb, so a full blood count belongs in the plan; the cited threshold for attention is a hematocrit above 52 to 54 percent.
- Limitation. The long end of the curve stays detectable far longer than the short end, so the preparation cannot be stopped quickly and is wrong for anyone sampled.
Side Effects and Management
The estrogenic picture and the red cell picture do not come from the same place, and telling them apart is what makes this single preparation manageable.
Post-Cycle Therapy
The slow end of the curve sets the start date: enanthate clears in about 14 to 16 days, undecylenate needs 3 to 4 weeks, and a SERM begun at the two-week mark has active boldenone against it.
